News Archive

2020

April

Media Release / Apr 03, 2020

Novartis and the Novartis US Foundation establish USD 5 million US COVID-19 Community Response Fund

Read More

March

Media Release / Mar 28, 2020

Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Read More
Media Release / Mar 28, 2020

Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Read More
Media Release / Mar 18, 2020

Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy

Read More
Media Release / Mar 18, 2020

Novartis Pharmaceuticals Corporation corrective action for certain blister packages of SANDIMMUNE® and NEORAL® 100-mg soft gelatin capsules in the US due to failure to meet child-resistant packaging requirements

Read More
Featured News / Mar 11, 2020

Novartis provides update on use and safety of Beovu® in patients with wet AMD

Read More

February

Scientists are working to develop drugs for individuals living with sickle cell disease
Story / Feb 24, 2020

Shaping the future of sickle cell disease

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

Read More
Featured News / Feb 12, 2020

Novartis launches new Preferred Firm Program for legal services

Read More
Media Release / Feb 11, 2020

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

Read More

January

Phil Gotwals and colleagues discuss advanced therapy platforms.
Story / Jan 09, 2020

Sourcing innovation, strategically

Phil Gotwals talks about his vision for the future of business development for research.

Read More

Related Links